Archive for December 22, 2022
December 22, 2022
Today, the U.S. Food and Drug Administration approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with human immunodeficiency virus type…
Latest Posts
FDA Awards Second Batch of National Priority Vouchers
November 6, 2025
FDA Acts to Protect Children from Unapproved Fluoride Drug Products
October 31, 2025
Tags
Animal & Veterinary
Award
Biologics
Coronavirus
Cosmetics
Dietary Supplements
Drugs
Follow @FDAmedia on Twitter
Follow @FDAMedia on X
Follow @US_FDA on Twitter
Follow @US_FDA on X
Follow FDA on Facebook
Food & Beverages
Infant Formula & Foods
Infectious Disease
Medical Devices
Office
Over-the-Counter Drugs
Press Announcements
Tobacco
Training
Vaccines

